Fig. 9From: Physicochemical and nanomedicine applications of phyto-reduced erbium oxide (Er2O3) nanoparticlesEffect of Er2O3 NPs therapy on serum lipids including total lipids, cholesterol, triglycerides, HDL and LDL. (A): Disease group; (B):Â Positive control group, (C): Er2O3 NPs treated group; (D): Normal groupBack to article page